silx
silx settles into maintenance a release after its PySide6 migration
Comparison · Analytics
OpenObserve vs pharmaversesdtm
A side-by-side editorial comparison of OpenObserve and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
OpenObserve vs pharmaversesdtm: at a glance
What is OpenObserve?
After its largest release, OpenObserve is patching the seams.
v0.92.0 landed on 7 August with 836 commits and three new product surfaces - synthetic monitoring, Workflows v1, and an expanded AI observability set - after a long RC series. The two releases since are small: v0.92.1 fixed alert HAVING clause typing and put the MCP server setup page on the OSS build, and v0.92.2 adds a compactor delay setting and backports an MCP 404 fix for deployments running under a base URI. The 0.91 line is still receiving its own backports.
What is pharmaversesdtm?
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
OpenObserve vs pharmaversesdtm: editorial side-by-side
OpenObserve
6.3ANALYTICS
After its largest release, OpenObserve is patching the seams.
◆ Current state
v0.92.0 landed on 7 August with 836 commits and three new product surfaces - synthetic monitoring, Workflows v1, and an expanded AI observability set - after a long RC series. The two releases since are small: v0.92.1 fixed alert HAVING clause typing and put the MCP server setup page on the OSS build, and v0.92.2 adds a compactor delay setting and backports an MCP 404 fix for deployments running under a base URI. The 0.91 line is still receiving its own backports.
◆ Where it's heading
OpenObserve is trying to become the whole monitoring stack rather than the storage layer under one. Synthetic checks, incident workflows, and SLO measurement each replace a separate tool, and incident ingestion from external alert sources hedges the migration path for teams that cannot switch all at once. The MCP work running alongside - open sourced, then given a setup page in the OSS build, then fixed for base-URI deployments - shows the same data being aimed at agent clients rather than dashboards.
◆ Prediction
The post-GA patches are still landing on the new surfaces, so expect another 0.92.x before feature work resumes - most likely hardening synthetic monitoring and Workflows, which are the two least-exercised additions.
pharmaversesdtm
0.0ANALYTICS
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
◆ Current state
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
◆ Where it's heading
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
◆ Prediction
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Alternatives to OpenObserve and pharmaversesdtm
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either OpenObserve or pharmaversesdtm.
Plotly
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread
aniread stops asking you to know which tracker wrote the file
Rho
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
OpenCTI
OpenCTI spends a release unblocking queues and hardening upserts
See all OpenObserve alternatives → · See all pharmaversesdtm alternatives →
Recent activity from OpenObserve and pharmaversesdtm
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1d agoOpenObservev0.92.2: compactor delay setting and an MCP base-URI fix
- 5d agoOpenObservev0.92.1 brings the MCP server setup page to the OSS build
- 11d agoOpenObservev0.92.0 adds synthetic monitoring, workflows, and AI observability ⚡
- 12d agoOpenObserveRelease candidate 4 backports fixes before the v0.92.0 GA
- 14d agoOpenObserveRC3 adds agent-level filters and parallel zstd compression
- 20d agoOpenObservev0.91.5 patches an RBAC migration and a layout bug
- 1mo agopharmaversesdtmLymphoma response data and geographic-atrophy tests
- 4mo agopharmaversesdtmCSV exports and microbiology domains for wider access
- 7mo agopharmaversesdtmNeurological SDTM datasets and Alzheimer's biomarkers
- 0y agopharmaversesdtmMaintainer and licensing update
- 1y agopharmaversesdtmMetabolic SDTM datasets and PCWG3 oncology response
- 1y agopharmaversesdtmGCIG response data and automated reference pages
Frequently asked questions
What is the difference between OpenObserve and pharmaversesdtm?
They serve adjacent needs but don't currently overlap on shipped themes. OpenObserve is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is OpenObserve better than pharmaversesdtm?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. OpenObserve is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to OpenObserve?
Top OpenObserve alternatives in Analytics are ranked by recent ship velocity. Browse the "OpenObserve alternatives" section above for the current picks, or visit /alternatives/openobserve for the full list with editorial commentary on each.
What are the best alternatives to pharmaversesdtm?
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.